Elinzanetant Patent Expiration
Elinzanetant was first introduced by Bayer Healthcare Pharmaceuticals Inc
Elinzanetant Patents
Given below is the list of patents protecting Elinzanetant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lynkuet | US10774091 | Mar 13, 2039 | Bayer Hlthcare | |
| Lynkuet | US11787820 | Mar 13, 2039 | Bayer Hlthcare | |
| Lynkuet | US12264164 | Mar 13, 2039 | Bayer Hlthcare | |
| Lynkuet | US10195205 | May 18, 2036 | Bayer Hlthcare | |
| Lynkuet | US7683056 | Sep 15, 2026 | Bayer Hlthcare |
Elinzanetant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List